Sustainable diet habits include behaviors like sticking to a diet plan and avoiding alcohol.
A new analysis of various diet habits suggests that sustainable habits, such as calorie counting, are viable options for people who can’t use GLP-1s for weight loss.1 Some of the data even suggests that using these habits may result in faster weight loss.
Digital Wellness used de-identified user data from the Mayo Clinic Diet, which showed that dieters in the program lost up to 13% of their weight in the first six months. During this same time period, people using GLP-1s lost about 2.3% of their body weight. The analysis also showed dieters that used sustainable weight loss methods typically kept the weight off for at least a year.
In a press release, medical editor of The Mayo Clinic Diet Dr. Donald Hensrud, MD, MS, said, “Early weight loss may be a signal that you can be successful with lifestyle alone. Adults who do not want or cannot tolerate weight-loss medications can achieve significant results from a healthy weight loss program."
Lead dietitian for The Mayo Clinic Diet Tara Schmidt added, “Practicing healthy habits is not about perfection. Responders didn't completely avoid sugar or alcohol, for example—they just practiced these habits more consistently than other members." Schmidt is also host of the Mayo Clinic on Nutrition podcast and co-author of The Mayo Clinic Diet: Weight-Loss Medications Edition.
The habits detailed in the analysis that led to sustainable weight loss were using a trusted diet plan, tracking food and drinks regularly, being mindful of sugar and alcohol consumption, regularly eating fruits and vegetables, and avoiding dining out too often.
The Mayo Clinic Diet isn’t against the use of weight loss medications, however. In January of this year, it announced the launching of a clinical weight loss solution that would provide patients with opportunities for virtual visits with board-certified doctors who could potentially provide access to weight loss medications.2
In a press release issued at the time, medical advisor to the Mayo Clinic Diet Andres J. Acosta, MD, PhD, said, “With this new program, Mayo Clinic Diet is now offering a complete clinical weight management solution. It provides valuable clinical support to ensure that patients use weight-loss medications effectively so they have every opportunity for weight-loss success.
Acosta continued, “Mayo Clinic Diet now offers three specially curated programs. Our flagship award-winning online diet program, an Rx companion program for those members currently using weight-loss medication, and the Medical Weight Loss Rx program launching today for new members looking for weight loss medication options."
The Mayo Clinic Diet previously discussed an Rx companion program in November of last year.3 At the time, Acosta said, “Weight loss medications can be a good tool for weight loss, but should be accompanied with lifestyle and diet behavior change programs like the Mayo Clinic Diet. Lifestyle changes are essential to prevent regain when weight-loss medications are discontinued. All of the breakthrough weight-loss medications available today were evaluated in studies that had important lifestyle components."
Johnson & Johnson Seeks FDA Approval for Subcutaneous Tremfya Regimen for Ulcerative Colitis
November 22nd 2024Johnson & Johnson has submitted a supplemental Biologics License Application to the FDA for a subcutaneous induction regimen of Tremfya for adults with moderately to severely active ulcerative colitis based on positive Phase III ASTRO trial results.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.